Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.04)
# 2,949
Out of 4,944 analysts
346
Total ratings
40.13%
Success rate
-9.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $57.33 | +39.54% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $65.12 | +15.18% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $43.10 | +50.81% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $4.42 | +216.74% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $18.93 | +428.26% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $15.30 | +194.12% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $36.95 | +102.98% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $10.73 | +179.59% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $26.87 | +63.75% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $20.40 | -50.98% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $10.71 | -6.63% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $11.00 | +172.73% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $26.87 | +365.20% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $9.05 | +65.75% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.17 | +327.35% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $3.47 | +44.09% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.78 | +181.69% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $4.74 | +216.46% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $21.16 | +112.67% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $3.08 | -2.60% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $11.81 | +238.70% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.53 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.94 | +260.82% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $1.59 | +88.68% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.53 | +275.09% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.53 | +1,604.55% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.56 | +128.66% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.29 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $1.04 | +58,625,560.74% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.47 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $57.33
Upside: +39.54%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $65.12
Upside: +15.18%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $43.10
Upside: +50.81%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $4.42
Upside: +216.74%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $18.93
Upside: +428.26%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $15.30
Upside: +194.12%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $36.95
Upside: +102.98%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $10.73
Upside: +179.59%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $26.87
Upside: +63.75%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $20.40
Upside: -50.98%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $10.71
Upside: -6.63%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $11.00
Upside: +172.73%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $26.87
Upside: +365.20%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $9.05
Upside: +65.75%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.17
Upside: +327.35%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $3.47
Upside: +44.09%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.78
Upside: +181.69%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $4.74
Upside: +216.46%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $21.16
Upside: +112.67%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $3.08
Upside: -2.60%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $11.81
Upside: +238.70%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.53
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.94
Upside: +260.82%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $1.59
Upside: +88.68%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.53
Upside: +275.09%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.53
Upside: +1,604.55%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $6.56
Upside: +128.66%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.29
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $1.04
Upside: +58,625,560.74%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $3.47
Upside: -